The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation
Open accessAbstract
BACKGROUND: Over the past decade, advances have been made in the care of patients undergoing transplantation. We conducted a study to determine whether these advances have improved the outcomes of transplantation. METHODS: We analyzed overall mortality, mortality not preceded by relapse, recurrent malignant conditions, and the frequency and severity of major complications of transplantation, including graft-versus-host disease (GVHD) and hepatic, renal, pulmonary, and infectious complications, among 1418 patients who received their first allogeneic transplants at our center in Seattle in the period from 1993 through 1997 and among 1148 patients who received their first allogeneic transplants in the period from 2003 through 2007. Components of the Pretransplant Assessment of Mortality (PAM) score were used in regression models to adjust for the severity of illness at the time of transplantation. RESULTS: In the 2003-2007 period, as compared with the 1993-1997 period, we observed significant decreases in mortality not preceded by relapse, both at day 200 (by 60%) and overall (by 52%), the rate of relapse or progression of a malignant condition (by 21%), and overall mortality (by 41%), after adjustment for components of the PAM score. The results were similar when the analyses were limited to patients who received myeloablative conditioning therapy. We also found significant decreases in the risk of severe GVHD; disease caused by viral, bacterial, and fungal infections; and damage to the liver, kidneys, and lungs. CONCLUSIONS: We found a substantial reduction in the hazard of death related to allogeneic hematopoietic-cell transplantation, as well as increased long-term survival, over the past decade. Improved outcomes appear to be related to reductions in organ damage, infection, and severe acute GVHD. (Funded by the National Institutes of Health.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Longitudinal data analysis using generalized linear models
LIANG, K.-Y., & ZEGER, S. L. (1986) · Biometrika · doi:10.1093/biomet/73.1.13 · Cited by 18,550
1994 Consensus Conference on Acute GVHD Grading.
Przepiorka, D., Weisdorf, D., Martin, P., Hg, K., Beatty, P., Hows, J., & Thomas, E. D. (1995) · PubMed · Cited by 5,037
Self-citationSorror, M. L., Maris, M. B., Storb, R., Baron, F., Sandmaier, B. M., Maloney, D. G., & Storer, B. (2005) · Blood · doi:10.1182/blood-2005-05-2004 · Cited by 2,969
Self-citationGooley, T. A., Leisenring, W., Crowley, J., & Storer, B. E. (1999) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19990330)18:6<695::aid-sim60>3.0.co;2-o · Cited by 2,688
Self-citationAscioglu, S., Rex, J. H., de Pauw, B., Bennett, J. E., Bille, J., Crokaert, F., Denning, D. W., Donnelly, J. P., Edwards, J. E., Erjavec, Z., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/323335 · Cited by 2,331
(2016) · Diagnostic Pathology: Hospital Autopsy · doi:10.1016/b978-0-323-37676-1.50073-x · Cited by 1,335
Lee, S. J., Klein, J., Haagenson, M., Baxter-Lowe, L. A., Confer, D. L., Eapen, M., Fernandez-Vina, M., Flomenberg, N., Horowitz, M., Hurley, C. K., et al. (2007) · Blood · doi:10.1182/blood-2007-06-097386 · Cited by 1,255
Definitions of Cytomegalovirus Infection and Disease in Transplant Recipients
Ljungman, P., Griffiths, P., & Paya, C. (2002) · Clinical Infectious Diseases · doi:10.1086/339329 · Cited by 1,234
Marr, K. A., Carter, R. A., Boeckh, M., Martin, P., & Corey, L. (2002) · Blood · doi:10.1182/blood-2002-05-1496 · Cited by 957
Self-citationHematopoietic Cell Transplantation
Forman, S. J., & Nakamura, R. (2015) · Blackwell Science Ltd eBooks · Cited by 659
Upton, A., Kirby, K. A., Carpenter, P., Boeckh, M., & Marr, K. A. (2007) · Clinical Infectious Diseases · doi:10.1086/510592 · Cited by 514
Self-citationFukuda, T., Boeckh, M., Carter, R. A., Sandmaier, B. M., Maris, M. B., Maloney, D. G., Martin, P. J., Storb, R. F., & Marr, K. A. (2003) · Blood · doi:10.1182/blood-2003-02-0456 · Cited by 465
Self-citation(2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.09.020 · Cited by 451
Thomas' Hematopoietic Cell Transplantation: Stem Cell Transplantation
(2009) · Wiley eBooks · doi:10.1002/9781444303537 · Cited by 440
de Lima, M., Couriel, D., Thall, P. F., Wang, X., Madden, T., Jones, R., Shpall, E. J., Shahjahan, M., Pierre, B., Giralt, S., et al. (2004) · Blood · doi:10.1182/blood-2004-02-0414 · Cited by 415
Storek, J., Dawson, M. A., Storer, B., Stevens-Ayers, T., Maloney, D. G., Marr, K. A., Witherspoon, R. P., Bensinger, W., Flowers, M. E. D., Martin, P., et al. (2001) · Blood · doi:10.1182/blood.v97.11.3380 · Cited by 397
Self-citationMcDonald, G. B., Slattery, J. T., Bouvier, M. E., Ren, S., Batchelder, A. L., Kalhorn, T. F., Schoch, H. G., Anasetti, C., & Gooley, T. (2003) · Blood · doi:10.1182/blood-2002-06-1860 · Cited by 383
Self-citationOptimization of Quantitative Detection of Cytomegalovirus DNA in Plasma by Real-Time PCR
Boeckh, M., Huang, M., Ferrenberg, J., Stevens-Ayers, T., Stensland, L., Nichols, W. G., & Corey, L. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.3.1142-1148.2004 · Cited by 260
Self-citationRuutu, T., Eriksson, B., Remes, K., Juvonen, E., Volin, L., Remberger, M., Parkkali, T., Hägglund, H., & Ringdén, O. (2002) · Blood · doi:10.1182/blood-2001-12-0159 · Cited by 251
Hakki, M., Riddell, S. R., Storek, J., Carter, R. A., Stevens-Ayers, T., Sudour, P., White, K., Corey, L., & Boeckh, M. (2003) · Blood · doi:10.1182/blood-2002-11-3472 · Cited by 250
Self-citationHepatobiliary Complications of Hematopoietic Cell Transplantation, 40 Years On†
McDonald, G. B. (2010) · Hepatology · doi:10.1002/hep.23533 · Cited by 201
Self-citationA Risk Score for Mortality after Allogeneic Hematopoietic Cell Transplantation
Parimon, T., Au, D. H., Martin, P. J., & Chien, J. W. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-6-200603210-00007 · Cited by 196
Self-citationBoeckh, M., Bowden, R. A., Gooley, T., Myerson, D., & Corey, L. (1999) · Blood · doi:10.1182/blood.v93.5.1781 · Cited by 162
Self-citationMartin, P. J., McDonald, G. B., Sanders, J. E., Anasetti, C., Appelbaum, F. R., Deeg, H. J., Nash, R. A., Petersdorf, E. W., Hansen, J. A., & Storb, R. F. (2004) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2003.12.304 · Cited by 157
Self-citationAcute renal failure after myeloablative hematopoietic cell transplant: Incidence and risk factors
Hingorani, S. R., Guthrie, K. A., Batchelder, A., Schoch, G. H., Aboulhosn, N., Manchion, J., & McDonald, G. B. (2004) · Kidney International · doi:10.1111/j.1523-1755.2005.00078.x · Cited by 131
Self-citationHockenbery, D. M., Cruickshank, S., Rodell, T. C., Gooley, T. A., Schuening, F., Rowley, S. D., David, D. S., Brunvand, M. M., Berryman, B., Abhyankar, S., et al. (2007) · Blood · doi:10.1182/blood-2006-05-021139 · Cited by 128
Self-citationClark, J. G., Madtes, D. K., Martin, T. R., Hackman, R. C., Farrand, A. L., & Crawford, S. W. (1999) · Critical Care Medicine · doi:10.1097/00003246-199909000-00016 · Cited by 97
Ursodeoxycholic Acid Treatment of Refractory Chronic Graft-versus-Host Disease of the Liver
Fried, R. H., Murakami, C. S., Fisher, L. D., Willson, R. A., Sullivan, K. M., & McDonald, G. B. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-8-624 · Cited by 92
Self-citationYokoe, D. S., Casper, C., Dubberke, E. R., Lee, G. M., Muñóz, P., Palmore, T. N., Sepkowitz, K. A., Young, J.-A. H., & Donnelly, J. P. (2009) · Bone Marrow Transplantation · doi:10.1038/bmt.2009.261 · Cited by 92
Gastrointestinal and Hepatic Complications
Strasser, S. I., & McDonald, G. B. (2009) · Wiley eBooks · doi:10.1002/9781444303537.ch95 · Cited by 78
Self-citationHingorani, S. R., Seidel, K. D., Lindner, A., Aneja, T., Schoch, G. H., & McDonald, G. B. (2008) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2008.09.015 · Cited by 77
Self-citationNarimatsu, H., Matsumura, T., Kami, M., Miyakoshi, S., Kusumi, E., Takagi, S., Miura, Y., Kato, D., Inokuchi, C., Myojo, T., et al. (2005) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2005.01.010 · Cited by 61
Chien, J. W., Boeckh, M. J., Hansen, J. A., & Clark, J. G. (2007) · Blood · doi:10.1182/blood-2007-09-101709 · Cited by 47
Self-citation
Cited by
Döhner, H., Weisdorf, D. J., & Bloomfield, C. D. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1406184 · Cited by 3,306
Wang, D. Y., Salem, J.-E., Cohen, J. V., Chandra, S., Menzer, C., Ye, F., Zhao, S., Das, S., Beckermann, K. E., Ha, L., et al. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2018.3923 · Cited by 2,674
Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance
Martins, F., Sofiya, L., Sykiotis, G. P., Lamine, F., Maillard, M., Fraga, M., Shabafrouz, K., Ribi, C., Cairoli, A., Guex-Crosier, Y., et al. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0218-0 · Cited by 2,314
Immune-checkpoint inhibitors: long-term implications of toxicity
Johnson, D. B., Nebhan, C. A., Moslehi, J. J., & Balko, J. M. (2022) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-022-00600-w · Cited by 982
Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation
Armand, P., Kim, H. T., Logan, B. R., Wang, Z., Alyea, E. P., Kalaycio, M. E., Maziarz, R. T., Antin, J. H., Soiffer, R. J., Weisdorf, D. J., et al. (2014) · Blood · doi:10.1182/blood-2014-01-552984 · Cited by 949
Metadata
- Authors
- Gooley, T. A., Chien, J. W., Pergam, S. A., Hingorani, S., Sorror, M. L., Boeckh, M., Martin, P. J., Sandmaier, B. M., Marr, K. A., Appelbaum, F. R., Storb, R., & McDonald, G. B.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2010-11-25
- Volume
- 363
- Issue
- 22
- Pages
- 2091-2101
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1995090169
- Cited by
- 1,493
- References
- 33
- FWCI
- 45.79
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.